A panel of experts discuss the role of PrEP in HIV prevention with a focus on current and newly approved options.
Back
Impact of Long-Acting HIV Prevention Drugs
A panel of experts discuss the role of PrEP in HIV prevention with a focus on current and newly approved options.
Impact of Long-Acting HIV Prevention Drugs
Episodes
All
All
Advertisement
Advertisement
Trending on Pharmacy Times
1
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal
2
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
3
The Side Door We Could Close: A Pharmacy Perspective on Menopause, Access, and the Leadership Pipeline
4
Study Reveals a Widening Gap Between Buprenorphine Prescribing and Dispensing
5